|
|
||||||||
Ann Thorac Surg 2001;71:1714-1715
© 2001 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
b Department of Cardiothoracic Anesthesia, MetroHealth Medical Center, Cleveland, Ohio, USA
Accepted for publication December 28, 2000.
* Address reprint requests to Dr Gill, Department of Cardiothoracic Surgery, The Cleveland Clinic Foundation, Hamann Building, 3rd Floor, 2500 MetroHealth Dr, Cleveland, OH 44109-1998 (Email: gillis{at}ccf.org).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Technique |
|---|
|
|
|---|
The patient was intubated, and a left thoracotomy was performed in the emergency department. The pericardium was found to be tense and was opened. After release of the tamponade, the patients hemodynamic status improved. On further examination of the heart, an entry wound in the left ventricular lateral wall measuring 2.5 cm was revealed. The bleeding was controlled by direct pressure, and the patient was rushed to the operating room. Heart rate was 130 beats per minute, and blood pressure was 80/50 mm Hg. A 12-mg intravenous bolus of adenosine (Adenocard) was injected into an 8F central trauma line inducing temporary asystole for a few seconds to allow accurate placement of 3-0 Teflon felt-pledgeted stitches (Ethicon Inc, Somerville, NJ) on the laceration in the left ventricle. The dose was repeated once. After the hemorrhage was controlled, the patients vital signs improved. Two chest tubes were placed, and the thoracotomy was closed. Postoperatively, except for confusion and short-term memory loss, the patient had an unremarkable clinical course and was transferred to a rehabilitation facility.
| Comment |
|---|
|
|
|---|
Adenosine is a purine nucleoside occurring in all cells of the body. A rapid bolus of intravenously administered adenosine produces acute inhibition of sinus node and atrioventricular node function, which can result in sinus bradycardia, transient atrioventricular block, and asystole [5]. These short-lived electrophysiologic effects have made adenosine an effective agent for restoring sinus rhythm in patients with supraventricular tachycardia [5] or for unmasking atrial tachyarrhythmias or ventricular preexcitation. Lately, adenosine has also proved to be a cardioprotective agent because of its coronary dilating effect [6] and its role in mediating ischemic preconditioning in patients undergoing off-pump coronary artery bypass grafting [7, 8]. It could also be used to facilitate accuracy in controlling conventional graft anastomotic bleeding.
The usual bolus dose of 6 to 12 mg of adenosine (0.15 to 0.3 mg/kg) should be rapidly injected through a large-bore central intravenous catheter and can be repeated. This low dose is sufficient to achieve temporary asystole within 30 seconds of injection and gives the surgeon time to do the repair on a motionless heart. Owing to adenosines ultrashort half-life, the asystolic period lasts for only a few seconds (15 to 20 seconds in our patient) with restoration of sinus rhythm afterward. When larger doses are given by infusion, adenosine lowers blood pressure by decreasing peripheral resistance. Phenylephrine hydrochloride can be given to expedite blood pressure recovery. Adverse effects consisting of flushing (44%), chest discomfort (40%), dyspnea (28%), headache (18%), first- and second-degree atrioventricular block (3%), and hypotension (2%) are dose related and usually resolve quickly once the drug is discontinued [6]. Rarely, acute bronchospasm can occur [9]. A full monitoring system, pacing backup, corrective measures for control of unwanted hemodynamic effects, and a safety net defibrillator system were available during the entire operation.
Because of the rapid onset and brief duration of action of adenosine, its intravenous administration during repair of penetrating cardiac injuries is safe and effective. Because adenosine causes temporary asystole, the surgeon has ample time to accurately place the required number of sutures in a semibloodless field and adequately control the hemorrhage.
| Addendum |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. A. Schwarte and M. Hartmann Intentional Circulatory Arrest to Facilitate Surgical Repair of a Massively Bleeding Artery Anesth. Analg., August 1, 2003; 97(2): 339 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Robicsek Induced ventricular fibrillation in the management of aortic arch trauma Ann. Thorac. Surg., January 1, 2002; 73(1): 342 - 342. [Full Text] [PDF] |
||||
![]() |
I. S. Gill, R. Lim, R. T. Temes, and C. E. Smith Induced ventricular fibrillation in the management of aortic arch trauma: Reply Ann. Thorac. Surg., January 1, 2002; 73(1): 342 - 342. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |